A Simple Blood Test Leading to Earlier Detection of Breast Cancer

Especially for women under age 55 who are at higher risk for developing breast cancer, the Oncimmune® Early Cancer Detection Test—Breast offers a blood test that helps increase the accuracy of detection.1 Used annually with mammography, EarlyCDT®-Breast:

  • Provides a simple procedure to detect cancer “markers” suggestive that a tumor might be present.
  • Tests for a variety of markers at once, thereby improving the chances of detection.
  • Can identify these markers up to four years earlier than mammography-detected breast cancer.

EarlyCDT® is not a genetic test, and it does not replace mammography or other imaging methods. It simply brings to light important information that mammography alone cannot always make available.

Sources:
1 Chapman, C., et al., March 2007, “Autoantibodies in Breast Cancer: Their Use as an Aid to Early Diagnosis.” Annals of Oncology (online publication), 18:868-873.